Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Passive leg movement enhances diuresis and decline of plasma NT-proBNP level in patients with decompensated heart failure treated with furosemide.

Wu Y, Chen B, Hong K, Hu W, Peng Q, Li Y, Cheng X, Su H.

Int J Cardiol. 2013 Oct 9;168(4):4289-90. doi: 10.1016/j.ijcard.2013.04.198. Epub 2013 May 21. No abstract available.

PMID:
23701937
2.

NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies.

Luers C, Sutcliffe A, Binder L, Irle S, Pieske B.

Clin Biochem. 2013 Aug;46(12):1013-9. doi: 10.1016/j.clinbiochem.2013.03.014. Epub 2013 Mar 28.

PMID:
23542086
3.

Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP.

Knebel F, Schimke I, Diaz Ramirez I, Schattke S, Eddicks S, Borges AC, Baumann G.

Int J Cardiol. 2009 May 15;134(2):260-3. doi: 10.1016/j.ijcard.2007.12.106. Epub 2008 Apr 1.

PMID:
18384896
4.

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.

Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, Hamid AK, Nicholls MG, Richards AM.

J Am Coll Cardiol. 2009 Dec 29;55(1):53-60. doi: 10.1016/j.jacc.2009.02.095.

5.

Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.

J Am Coll Cardiol. 2008 May 13;51(19):1874-82. doi: 10.1016/j.jacc.2007.12.051.

6.
7.

Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.

Rademaker MT, Charles CJ, Nicholls MG, Richards AM.

Circ Heart Fail. 2009 Nov;2(6):532-40. doi: 10.1161/CIRCHEARTFAILURE.109.861336. Epub 2009 Sep 22.

8.

Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study.

Mohammed AA, van Kimmenade RR, Richards M, Bayes-Genis A, Pinto Y, Moore SA, Januzzi JL Jr.

Circ Heart Fail. 2010 May;3(3):354-61. doi: 10.1161/CIRCHEARTFAILURE.109.915280. Epub 2010 Mar 23.

9.

Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.

Cataliotti A, Boerrigter G, Costello-Boerrigter LC, Schirger JA, Tsuruda T, Heublein DM, Chen HH, Malatino LS, Burnett JC Jr.

Circulation. 2004 Apr 6;109(13):1680-5. Epub 2004 Mar 15.

10.

NT-proBNP in monitoring treatment of patients with congestive heart failure.

Al-Meslmani BM, Fahoum SK, Shamia MG.

Clin Lab. 2007;53(1-2):35-9.

PMID:
17323823
11.
12.

Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.

Aaser E, Gullestad L, Tølløfsrud S, Lundberg J, Hall C, Djøseland O, Kjekshus J, Forfang K.

Scand J Clin Lab Invest. 1997 Jul;57(4):361-7.

PMID:
9249883
13.

Natriuretic peptide-guided management of acutely destabilized heart failure: rationale and treatment algorithm.

Bhardwaj A, Januzzi JL Jr.

Crit Pathw Cardiol. 2009 Dec;8(4):146-50. doi: 10.1097/HPC.0b013e3181c4a0c6. Review.

PMID:
19952548
14.

Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.

Libetta C, Sepe V, Zucchi M, Pisacco P, Cosmai L, Meloni F, Campana C, Rampino T, Monti C, Tavazzi L, Dal Canton A.

Nephrol Dial Transplant. 2007 Jul;22(7):2013-9. Epub 2007 Feb 13.

PMID:
17298996
15.

[Biomarkers in heart failure: BNP and NT-proBNP].

Ho CC, Liu CC.

Hu Li Za Zhi. 2009 Oct;56(5):16-22. Review. Chinese.

PMID:
19760573
16.
17.

Probrain natriuretic peptide for assessment of efficacy in heart failure treatment.

Ozkara A, Turgut F, Selcoki Y, Karanfil A, Metin MR, Kanbay M, Tekin O, Akcay A.

Adv Ther. 2007 Nov-Dec;24(6):1233-9.

PMID:
18165205
18.

Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.

Kubler P, Jankowska EA, Majda J, Reczuch K, Banasiak W, Ponikowski P.

Int J Cardiol. 2008 Oct 13;129(3):373-8. Epub 2007 Dec 4.

PMID:
18054808
19.

Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.

Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP; TIME-CHF Investigators.

Circ Heart Fail. 2014 Jan;7(1):131-9. doi: 10.1161/CIRCHEARTFAILURE.113.000527. Epub 2013 Dec 18.

20.

The impact of amino-terminal pro-brain natriuretic peptide testing on hospital length of stay and morbidity in patients with acute decompensated heart failure.

Green SM, Redmond P, Januzzi JL, Aleryani S, Lee-Lewandrowski E, Sluss P, Lewandrowski KB.

Arch Pathol Lab Med. 2007 Mar;131(3):473-6.

PMID:
17516751

Supplemental Content

Support Center